Cargando…
Antiretroviral (ARV) Drug Resistance and HIV-1 Subtypes among Injecting Drug Users in the Coastal Region of Kenya
HIV-1 genetic diversity results into the development of widespread drug-resistant mutations (DRMs) for the first-line retroviral therapy. Nevertheless, few studies have investigated the relationship between DRMs and HIV-1 subtypes among HIV-positive injecting drug users (IDUs). This study therefore...
Autores principales: | Ng'ong'a, Gabriel O., Ayodo, George, Kawaka, Fanuel, Knight, Veronicah, Ngayo, Musa, Lwembe, Raphael M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853818/ https://www.ncbi.nlm.nih.gov/pubmed/35186083 http://dx.doi.org/10.1155/2022/3217749 |
Ejemplares similares
-
Fungi and Aflatoxin Levels in Traditionally Processed Cassava (Manihot esculenta Crantz) Products in Homa Bay County, Kenya
por: Obong'o, Boniface Oure, et al.
Publicado: (2020) -
New ARV drugs
por: Gulick, Roy
Publicado: (2014) -
HIV type 1 drug resistance patterns among patients failing first and second line antiretroviral therapy in Nairobi, Kenya
por: Koigi, Peter, et al.
Publicado: (2014) -
Patent Pooling for Promoting Access to Antiretroviral Drugs (ARVs) – A Strategic Option for India
por: Satyanarayana, Kanikaram, et al.
Publicado: (2010) -
Adverse drug reactions to antiretroviral therapy (ARVs): incidence, type and risk factors in Nigeria
por: Eluwa, George I, et al.
Publicado: (2012)